Cargando…
Tailoring the Antibody Response to Aggregated Aß Using Novel Alzheimer-Vaccines
Recent evidence suggests Alzheimer-Disease (AD) to be driven by aggregated Aß. Capitalizing on the mechanism of molecular mimicry and applying several selection layers, we screened peptide libraries for moieties inducing antibodies selectively reacting with Aß-aggregates. The technology identified a...
Autores principales: | Mandler, Markus, Santic, Radmila, Gruber, Petra, Cinar, Yeliz, Pichler, Dagmar, Funke, Susanne Aileen, Willbold, Dieter, Schneeberger, Achim, Schmidt, Walter, Mattner, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303436/ https://www.ncbi.nlm.nih.gov/pubmed/25611858 http://dx.doi.org/10.1371/journal.pone.0115237 |
Ejemplares similares
-
Peptides for Therapy and Diagnosis of Alzheimer’s Disease
por: Funke, Susanne Aileen, et al.
Publicado: (2012) -
The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity
por: Widera, Marek, et al.
Publicado: (2014) -
Characterization of a Single-Chain Variable Fragment Recognizing a Linear Epitope of Aβ: A Biotechnical Tool for Studies on Alzheimer’s Disease?
por: Dornieden, Silke, et al.
Publicado: (2013) -
Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer’s disease
por: Landlinger, Christine, et al.
Publicado: (2015) -
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
por: Mandler, Markus, et al.
Publicado: (2015)